首页 > 最新文献

American Journal of Transplantation最新文献

英文 中文
Comment on "Cellular and Humoral Immunogenicity of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients". 对“实体器官移植受者呼吸道合胞病毒免疫接种的细胞和体液免疫原性”的评论。
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-08 DOI: 10.1016/j.ajt.2025.12.003
S Dhanya Dedeepya,Vaishali Goel,Nivedita Nikhil Desai
{"title":"Comment on \"Cellular and Humoral Immunogenicity of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients\".","authors":"S Dhanya Dedeepya,Vaishali Goel,Nivedita Nikhil Desai","doi":"10.1016/j.ajt.2025.12.003","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.12.003","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"6 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145718024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post Transplant Outcomes with Prolonged Donor Heart Ischemic Time in the Pediatric Population 儿童移植后供体心脏缺血时间延长的预后
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-06 DOI: 10.1016/j.ajt.2025.12.002
Shannon Oliver MBBS, Jennifer Conway MD, Michael Khoury MD, Dean Eurich PhD, Cerina Dubois PhD, Katherine Bedard MSc, Simon Urschel MD, Tara Pidborochynski MSc, Lori West MD DPhil, Mohammed Al-Aklabi MD, Devilliers Jonker MD, Darren H. Freed MD PhD
Avoiding grafts with ischemic time (IT) >6h continues to be advised in pediatric heart transplant (HTx). We sought to evaluate the association between IT and clinical outcomes in a geographically remote center. This was a retrospective single-center analysis of patients transplanted between 01/1995 and 12/2020. Baseline characteristics and post-HTx outcomes were compared across three IT groups (<4.5h, 4.5–6h and >6h) with results reported in that order. Cox proportional hazard modelling was used to determine factors associated with graft failure. Of the 188 patients, 56.4% were male, median age was 3.0 years (IQR 0.6, 10.2) and 46.3% had congenital heart disease. IT was evenly distributed amongst the cohort (37.2% vs 31.4% vs 31.4%). There were no differences in early post-HTx morbidity, including primary graft dysfunction (2.9% vs 1.7% vs 5.3% p=0.5). Compared to IT <4.5h, longer IT was not associated with graft failure [IT 4.5–6: HR 1.10 (0.50–2.39), p=0.810 and [IT >6hr: HR 1.10 (0.52–2.35), p=0.797]. In our population, IT was not an independent risk factor for post-HTx morbidity or graft failure. Use of a modified del Nido preservation solution and experience with prolonged IT donors may have contributed to our outcomes.
在儿童心脏移植(HTx)中,仍然建议避免缺血时间(IT) 6h的移植物。我们试图在一个地理位置偏远的中心评估信息技术与临床结果之间的关系。这是一项针对1995年1月1日至2020年12月间移植患者的回顾性单中心分析。基线特征和htx后的结果在三个IT组(<4.5h, 4.5-6h和>;6h)之间进行比较,并按顺序报告结果。Cox比例风险模型用于确定与移植物衰竭相关的因素。188例患者中,56.4%为男性,中位年龄为3.0岁(IQR 0.6, 10.2), 46.3%患有先天性心脏病。IT在队列中分布均匀(37.2% vs 31.4% vs 31.4%)。htx术后早期发病率无差异,包括原发性移植物功能障碍(2.9% vs 1.7% vs 5.3% p=0.5)。与IT <;4.5h相比,更长时间的IT与移植物衰竭无关[IT <; 4.5-6: HR 1.10 (0.50-2.39), p=0.810]和[IT <; 6小时:HR 1.10 (0.52-2.35), p=0.797]。在我们的人群中,IT不是htx术后发病率或移植物失败的独立危险因素。使用改良的del Nido保存液和长期IT供体的经验可能有助于我们的结果。
{"title":"Post Transplant Outcomes with Prolonged Donor Heart Ischemic Time in the Pediatric Population","authors":"Shannon Oliver MBBS, Jennifer Conway MD, Michael Khoury MD, Dean Eurich PhD, Cerina Dubois PhD, Katherine Bedard MSc, Simon Urschel MD, Tara Pidborochynski MSc, Lori West MD DPhil, Mohammed Al-Aklabi MD, Devilliers Jonker MD, Darren H. Freed MD PhD","doi":"10.1016/j.ajt.2025.12.002","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.12.002","url":null,"abstract":"Avoiding grafts with ischemic time (IT) &gt;6h continues to be advised in pediatric heart transplant (HTx). We sought to evaluate the association between IT and clinical outcomes in a geographically remote center. This was a retrospective single-center analysis of patients transplanted between 01/1995 and 12/2020. Baseline characteristics and post-HTx outcomes were compared across three IT groups (&lt;4.5h, 4.5–6h and &gt;6h) with results reported in that order. Cox proportional hazard modelling was used to determine factors associated with graft failure. Of the 188 patients, 56.4% were male, median age was 3.0 years (IQR 0.6, 10.2) and 46.3% had congenital heart disease. IT was evenly distributed amongst the cohort (37.2% vs 31.4% vs 31.4%). There were no differences in early post-HTx morbidity, including primary graft dysfunction (2.9% vs 1.7% vs 5.3% p=0.5). Compared to IT &lt;4.5h, longer IT was not associated with graft failure [IT 4.5–6: HR 1.10 (0.50–2.39), p=0.810 and [IT &gt;6hr: HR 1.10 (0.52–2.35), p=0.797]. In our population, IT was not an independent risk factor for post-HTx morbidity or graft failure. Use of a modified del Nido preservation solution and experience with prolonged IT donors may have contributed to our outcomes.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"16 1 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145697401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical controversies in organ procurement: A national survey on public perceptions of thoracoabdominal normothermic regional perfusion. 器官获取中的伦理争议:一项全国公众对胸腹恒温区域灌注认知的调查。
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-04 DOI: 10.1016/j.ajt.2025.12.001
Trevor M Bibler,Jill Oliver Robinson,Adam Omelianchuk,Tariq Nisar,Savitri Fedson,Ariel N Levchenko,Amy L McGuire
Thoracoabdominal normothermic regional perfusion (TA-NRP) would likely expand the quantity and quality of organs procured after controlled circulatory-death donation in the United States, yet its ethical permissibility remains contested. We surveyed a representative sample of U.S. adults (n = 975) with the goal of assessing their perspectives on the ethical permissibility of TA-NRP. After reading a neutral description of TA-NRP, participants judged its permissibility, reviewed five critic and five supporter arguments (in random order), and chose which argument they found most convincing. Multivariable logistic regression examined predictors of agreeing with critics. Before exposure to the arguments, 51.5% stated that TA-NRP should be used, 34.2% were uncertain, and 14.4% stated it should not be used. After reviewing arguments, 60.6% agreed with supporters and 39.4% with critics. Two-thirds of those initially uncertain sided with critics. Agreement with critics was associated with religious-service attendance, less trust in doctors, non-registration as an organ donor, and being Black/African American. Participants who agreed with supporters cited TA-NRP's capacity to benefit more patients, whereas those who agreed with critics doubt that donors are irreversibly dead. While the majority supports TA-NRP, a substantial minority-concentrated among religious, distrustful, and historically underserved participants-remains unconvinced.
在美国,胸腹恒温区域灌注(TA-NRP)可能会扩大受控循环死亡捐赠后获得器官的数量和质量,但其伦理许可仍存在争议。我们调查了一个有代表性的美国成年人样本(n = 975),目的是评估他们对TA-NRP的伦理容忍度的看法。在阅读了对TA-NRP的中立描述后,参与者判断其可接受性,回顾了五个批评者和五个支持者的论点(以随机顺序),并选择他们认为最具说服力的论点。多变量逻辑回归检验了同意批评的预测因素。51.5%的人认为应该使用TA-NRP, 34.2%的人不确定,14.4%的人认为不应该使用TA-NRP。调查结果显示,60.6%的人表示支持,39.4%的人表示反对。最初不确定的人中有三分之二站在了批评者一边。与批评意见一致的人参加宗教活动、对医生的信任度较低、未登记为器官捐赠者,以及是黑人/非裔美国人。支持TA-NRP的人认为TA-NRP有能力使更多的病人受益,而反对TA-NRP的人则怀疑捐赠者的死亡是不可逆转的。虽然大多数人支持TA-NRP,但仍有相当数量的少数人——集中在宗教、不信任和历史上服务不足的参与者中——仍然不相信。
{"title":"Ethical controversies in organ procurement: A national survey on public perceptions of thoracoabdominal normothermic regional perfusion.","authors":"Trevor M Bibler,Jill Oliver Robinson,Adam Omelianchuk,Tariq Nisar,Savitri Fedson,Ariel N Levchenko,Amy L McGuire","doi":"10.1016/j.ajt.2025.12.001","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.12.001","url":null,"abstract":"Thoracoabdominal normothermic regional perfusion (TA-NRP) would likely expand the quantity and quality of organs procured after controlled circulatory-death donation in the United States, yet its ethical permissibility remains contested. We surveyed a representative sample of U.S. adults (n = 975) with the goal of assessing their perspectives on the ethical permissibility of TA-NRP. After reading a neutral description of TA-NRP, participants judged its permissibility, reviewed five critic and five supporter arguments (in random order), and chose which argument they found most convincing. Multivariable logistic regression examined predictors of agreeing with critics. Before exposure to the arguments, 51.5% stated that TA-NRP should be used, 34.2% were uncertain, and 14.4% stated it should not be used. After reviewing arguments, 60.6% agreed with supporters and 39.4% with critics. Two-thirds of those initially uncertain sided with critics. Agreement with critics was associated with religious-service attendance, less trust in doctors, non-registration as an organ donor, and being Black/African American. Participants who agreed with supporters cited TA-NRP's capacity to benefit more patients, whereas those who agreed with critics doubt that donors are irreversibly dead. While the majority supports TA-NRP, a substantial minority-concentrated among religious, distrustful, and historically underserved participants-remains unconvinced.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"93 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assuring Microbiological Safety in Clinical Xenotransplantation. 确保临床异种器官移植的微生物安全性。
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-04 DOI: 10.1016/j.ajt.2025.11.027
Jay A Fishman
{"title":"Assuring Microbiological Safety in Clinical Xenotransplantation.","authors":"Jay A Fishman","doi":"10.1016/j.ajt.2025.11.027","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.027","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"15 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-acute sequelae following Omicron COVID-19 in transplant recipients: a population-based cohort study. 移植受者的Omicron COVID-19急性后后遗症:一项基于人群的队列研究
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-02 DOI: 10.1016/j.ajt.2025.11.025
Liang En Wee,Yong Yi Tan,Muhammad Ismail Bin Abdul Malek,Jue Tao Lim,Calvin J Chiew,David Chien Lye,Kelvin Bryan Tan
Population-based studies evaluating long-COVID-19 prevalence in transplant recipients are limited. We examined risk of new-incident multi-systemic sequelae post-SARS-CoV-2 Omicron infection in a retrospective population-based cohort of transplant recipients, versus test-negatives. National COVID-19/healthcare-claims databases were utilised to construct cohorts of all Singaporean adult transplant recipients infected during Omicron-predominance (1st Jan-31st Dec 2022), and contemporaneous test-negatives. Competing risks regression (death as a competing risk), with overlap weights applied, was utilised to estimate risks of new-incident diagnoses/symptoms 31-300 days post-SARS-CoV-2 infection in transplant recipients, versus test-negatives. 1,890 SARS-CoV-2 infected transplant recipients and 1,482 test-negatives were included. 88.7% were boosted. Overall risks of post-acute sequelae were not significantly increased in SARS-CoV-2-infected transplant recipients, versus test-negatives (any post-acute diagnosis: adjusted-hazards-ratio, aHR=1.35[95%CI=0.74-2.45]; any post-acute symptom: aHR=1.06[95%CI=0.52-2.17]). However, increased risk of post-acute autoimmune (aHR=5.34[95%CI=1.03-27.62])/neurological sequelae (aHR=3.06[95%CI=1.23-7.61]) were observed in SARS-CoV-2-infected transplant recipients versus test-negatives; though excess-burden was modest (autoimmune: EB-per-1000-individuals=5.58[95%CI=-4.49-15.65]; neurological: EB-per-1000-individuals=19.82[95%CI=-4.33-43.96]). Risks of post-acute neurological/autoimmune sequelae remained elevated in untreated COVID-19 cases versus test-negatives but did not significantly differ in treated COVID-19 cases versus test-negatives. We conclude that overall risk of post-acute sequelae was not significantly elevated in a highly-vaccinated/boosted cohort of Omicron SARS-CoV-2-infected transplant recipients, versus test-negatives. COVID-19 vaccination/boosting remains important during endemicity.
评估移植受者中长期covid -19流行率的基于人群的研究是有限的。我们在以人群为基础的移植受者回顾性队列中检测了sars - cov -2组粒感染后新发多系统后遗症的风险,与检测阴性的风险进行了比较。利用国家COVID-19/医疗索赔数据库构建了所有新加坡成年移植受者在欧米克隆显性期间(2022年1月1日至12月31日)感染和同期检测阴性的队列。竞争风险回归(死亡作为竞争风险)采用重叠权重,用于估计移植受者在sars - cov -2感染后31-300天内与检测阴性相比新发诊断/症状的风险。包括1890名感染SARS-CoV-2的移植受者和1482名检测阴性者。提高了88.7%。sars - cov -2感染的移植受者与检测阴性的移植受者相比,急性后后遗症的总体风险没有显著增加(任何急性后诊断:校正危险比,aHR=1.35[95%CI=0.74-2.45];任何急性后症状:aHR=1.06[95%CI=0.52-2.17])。然而,sars - cov -2感染的移植受者与检测阴性者相比,急性后自身免疫(aHR=5.34[95%CI=1.03-27.62])/神经系统后遗症(aHR=3.06[95%CI=1.23-7.61])的风险增加;尽管过度负担是适度的(自身免疫:eb -1000人=5.58[95%CI=-4.49-15.65];神经系统:eb -1000人=19.82[95%CI=-4.33-43.96])。未经治疗的COVID-19病例与检测阴性的病例相比,急性后神经系统/自身免疫性后遗症的风险仍然升高,但治疗的COVID-19病例与检测阴性的病例没有显著差异。我们的结论是,与检测阴性的移植受者相比,高度接种/增强的Omicron sars - cov -2感染移植受者的急性后后遗症的总体风险没有显著升高。COVID-19疫苗接种/加强在流行期间仍然很重要。
{"title":"Post-acute sequelae following Omicron COVID-19 in transplant recipients: a population-based cohort study.","authors":"Liang En Wee,Yong Yi Tan,Muhammad Ismail Bin Abdul Malek,Jue Tao Lim,Calvin J Chiew,David Chien Lye,Kelvin Bryan Tan","doi":"10.1016/j.ajt.2025.11.025","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.025","url":null,"abstract":"Population-based studies evaluating long-COVID-19 prevalence in transplant recipients are limited. We examined risk of new-incident multi-systemic sequelae post-SARS-CoV-2 Omicron infection in a retrospective population-based cohort of transplant recipients, versus test-negatives. National COVID-19/healthcare-claims databases were utilised to construct cohorts of all Singaporean adult transplant recipients infected during Omicron-predominance (1st Jan-31st Dec 2022), and contemporaneous test-negatives. Competing risks regression (death as a competing risk), with overlap weights applied, was utilised to estimate risks of new-incident diagnoses/symptoms 31-300 days post-SARS-CoV-2 infection in transplant recipients, versus test-negatives. 1,890 SARS-CoV-2 infected transplant recipients and 1,482 test-negatives were included. 88.7% were boosted. Overall risks of post-acute sequelae were not significantly increased in SARS-CoV-2-infected transplant recipients, versus test-negatives (any post-acute diagnosis: adjusted-hazards-ratio, aHR=1.35[95%CI=0.74-2.45]; any post-acute symptom: aHR=1.06[95%CI=0.52-2.17]). However, increased risk of post-acute autoimmune (aHR=5.34[95%CI=1.03-27.62])/neurological sequelae (aHR=3.06[95%CI=1.23-7.61]) were observed in SARS-CoV-2-infected transplant recipients versus test-negatives; though excess-burden was modest (autoimmune: EB-per-1000-individuals=5.58[95%CI=-4.49-15.65]; neurological: EB-per-1000-individuals=19.82[95%CI=-4.33-43.96]). Risks of post-acute neurological/autoimmune sequelae remained elevated in untreated COVID-19 cases versus test-negatives but did not significantly differ in treated COVID-19 cases versus test-negatives. We conclude that overall risk of post-acute sequelae was not significantly elevated in a highly-vaccinated/boosted cohort of Omicron SARS-CoV-2-infected transplant recipients, versus test-negatives. COVID-19 vaccination/boosting remains important during endemicity.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"1 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Will the flu vaccine work this year? Concerns about Influenza subclade K. 流感疫苗今年会起作用吗?对流感K亚型的关注。
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-12-01 DOI: 10.1016/j.ajt.2025.11.026
Marcus R Pereira
{"title":"Will the flu vaccine work this year? Concerns about Influenza subclade K.","authors":"Marcus R Pereira","doi":"10.1016/j.ajt.2025.11.026","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.026","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"157 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145664098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on: Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study 肾移植排斥后供体来源的无细胞DNA动力学与临床结果之间的关系:一项前瞻性、多中心研究
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-11-29 DOI: 10.1016/j.ajt.2025.11.022
Suphamai Bunnapradist, Hossein Tabriziani, Yasir Qazi
{"title":"Response to Comment on: Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study","authors":"Suphamai Bunnapradist, Hossein Tabriziani, Yasir Qazi","doi":"10.1016/j.ajt.2025.11.022","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.022","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"1 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individual Clinician Decisions and the Future Role of AI in Deceased Donor Kidney Transplantation 临床医生的个人决定和人工智能在已故供肾移植中的未来作用
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-11-29 DOI: 10.1016/j.ajt.2025.11.020
Ellen Green, E.Glenn Dutcher, Jesse D. Schold, Darren Stewart
{"title":"Individual Clinician Decisions and the Future Role of AI in Deceased Donor Kidney Transplantation","authors":"Ellen Green, E.Glenn Dutcher, Jesse D. Schold, Darren Stewart","doi":"10.1016/j.ajt.2025.11.020","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.020","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"36 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities Through the Looking Glass 镜子中的不平等
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-11-29 DOI: 10.1016/j.ajt.2025.11.024
Raymond C. Givens MD PhD
{"title":"Disparities Through the Looking Glass","authors":"Raymond C. Givens MD PhD","doi":"10.1016/j.ajt.2025.11.024","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.024","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"72 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chicken or the Egg: Discerning the relationship between delayed graft function and cardiovascular complications 鸡还是蛋:识别移植延迟功能与心血管并发症之间的关系
IF 8.8 2区 医学 Q1 SURGERY Pub Date : 2025-11-29 DOI: 10.1016/j.ajt.2025.11.023
Ryan N. McGinn, Stuart A. McCluskey
{"title":"Chicken or the Egg: Discerning the relationship between delayed graft function and cardiovascular complications","authors":"Ryan N. McGinn, Stuart A. McCluskey","doi":"10.1016/j.ajt.2025.11.023","DOIUrl":"https://doi.org/10.1016/j.ajt.2025.11.023","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"32 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Transplantation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1